Peptide record

TPDB11714

Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity standard
37 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11714
Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP pep-lab Peptipedia ACP740 _ACP240 AntiCP 2.0 iACP-DRLF Antifungipept APD_complete HemoPI Hemolytic2 PD_Hemolysis
standard
No
A 37-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSEFFQS
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C192H320N60O56
ANCHMPTWYV
RL
4365.02
10.76
9
6
12
+3
3.26
-0.724
94.86
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
6
Residue Composition
number
0
A
6
R
0
N
3
D
0
C
3
E
2
Q
4
G
0
H
3
I
6
L
3
K
0
M
3
F
0
P
4
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 6 N: 0 D: 3 C: 0 E: 3 Q: 2 G: 4 H: 0 I: 3 L: 6 K: 3 M: 0 F: 3 P: 0 S: 4 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
37 reviewed residue count
C192H320N60O56 sequence-only estimate (linear, free termini)
4365.02 sequence-only estimate (linear, free termini)
10.76 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
3.26 sequence-only estimate (linear, free termini)
-0.724 sequence-only estimate (linear, free termini)
Evidence Records 39 records
Evidence 1 Activity

Activity

MIC
Antibacterial
4 µM

Target

B. megaterium Bm11

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
active against Gram+ S. aureus ATCC25923 or Cowan 1 (MIC 32-64), B. megaterium Bm11 (MIC 4 uM), S. epidermidis LY8 (MIC 25 ug/ml), L. monocytogenes CICC21634 or CICC21533 (MIC 4-125 ug
Evidence 2 Activity

Activity

MIC
Antibacterial
25 µg/mL

Target

Staphylococcus epidermidis LY8

Source & Reference

dbAMP DRAMP

Other

against Gram+ S. aureus ATCC25923 or Cowan 1 (MIC 32-64), B. megaterium Bm11 (MIC 4 uM), S. epidermidis LY8 (MIC 25 ug/ml), L. monocytogenes CICC21634 or CICC21533 (MIC 4-125 ug/ml), B. subtilis CICC24434 (MIC 1.
Evidence 3 Activity

Activity

MIC
Antibacterial
4-125 µg/mL

Target

L. monocytogenes CICC21634 or CICC21533

Source & Reference

dbAMP DRAMP

Other

or Cowan 1 (MIC 32-64), B. megaterium Bm11 (MIC 4 uM), S. epidermidis LY8 (MIC 25 ug/ml), L. monocytogenes CICC21634 or CICC21533 (MIC 4-125 ug/ml), B. subtilis CICC24434 (MIC 1.56 ug/ml), B. Globigii (MIC 0.6 uM), Gram- S. choleraesuis
Evidence 4 Activity

Activity

MIC
Antibacterial
1.56 µg/mL

Target

B. subtilis CICC24434

Source & Reference

dbAMP DRAMP

Other

pidermidis LY8 (MIC 25 ug/ml), L. monocytogenes CICC21634 or CICC21533 (MIC 4-125 ug/ml), B. subtilis CICC24434 (MIC 1.56 ug/ml), B. Globigii (MIC 0.6 uM), Gram- S. choleraesuis C78-1 (MIC 1.56 ug/ml), S. typhimurium S
Evidence 5 Activity

Activity

MIC
Antibacterial
0.6 µM

Target

B. Globigii

Source & Reference

dbAMP DRAMP

Other

togenes CICC21634 or CICC21533 (MIC 4-125 ug/ml), B. subtilis CICC24434 (MIC 1.56 ug/ml), B. Globigii (MIC 0.6 uM), Gram- S. choleraesuis C78-1 (MIC 1.56 ug/ml), S. typhimurium SL1344 (MIC 3.12-4 ug/ml),
Evidence 6 Activity

Activity

MIC
Antibacterial
1.56 µg/mL

Target

S. choleraesuis C78-1

Source & Reference

dbAMP DRAMP

Other

MIC 4-125 ug/ml), B. subtilis CICC24434 (MIC 1.56 ug/ml), B. Globigii (MIC 0.6 uM), Gram- S. choleraesuis C78-1 (MIC 1.56 ug/ml), S. typhimurium SL1344 (MIC 3.12-4 ug/ml), P. avium C48-3 (MIC 3.12 ug/ml), S. choleraesu
Evidence 7 Activity

Activity

MIC
Antibacterial
3.12-4 µg/mL

Target

S. typhimurium SL1344

Source & Reference

dbAMP DRAMP

Other

(MIC 1.56 ug/ml), B. Globigii (MIC 0.6 uM), Gram- S. choleraesuis C78-1 (MIC 1.56 ug/ml), S. typhimurium SL1344 (MIC 3.12-4 ug/ml), P. avium C48-3 (MIC 3.12 ug/ml), S. choleraesuis C78-1 (MIC 1.56 ug/ml), E. coli ATCC 25
Evidence 8 Activity

Activity

MIC
Antibacterial
3.12 µg/mL

Target

P. avium C48-3

Source & Reference

dbAMP DRAMP

Other

, Gram- S. choleraesuis C78-1 (MIC 1.56 ug/ml), S. typhimurium SL1344 (MIC 3.12-4 ug/ml), P. avium C48-3 (MIC 3.12 ug/ml), S. choleraesuis C78-1 (MIC 1.56 ug/ml), E. coli ATCC 25922 (MIC 1-2 uM), and P. aerugino
Evidence 9 Activity

Activity

MIC
Antibacterial
1.56 µg/mL

Target

S. choleraesuis C78-1

Source & Reference

dbAMP DRAMP

Other

C 1.56 ug/ml), S. typhimurium SL1344 (MIC 3.12-4 ug/ml), P. avium C48-3 (MIC 3.12 ug/ml), S. choleraesuis C78-1 (MIC 1.56 ug/ml), E. coli ATCC 25922 (MIC 1-2 uM), and P. aeruginosa ATCC 27853 or PAO1 (MIC 1.25-2.5 uM).
Evidence 10 Activity

Activity

MIC
Antibacterial
1-2 µM

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP DRAMP

Other

C 3.12-4 ug/ml), P. avium C48-3 (MIC 3.12 ug/ml), S. choleraesuis C78-1 (MIC 1.56 ug/ml), E. coli ATCC 25922 (MIC 1-2 uM), and P. aeruginosa ATCC 27853 or PAO1 (MIC 1.25-2.5 uM). Anti-inflammatory: Bind LPS, sup
Evidence 11 Activity

Activity

MIC
Antibacterial
1.25-2.5 µM

Target

Pseudomonas aeruginosa ATCC 27853 or PAO1

Source & Reference

dbAMP DRAMP

Other

3.12 ug/ml), S. choleraesuis C78-1 (MIC 1.56 ug/ml), E. coli ATCC 25922 (MIC 1-2 uM), and P. aeruginosa ATCC 27853 or PAO1 (MIC 1.25-2.5 uM). Anti-inflammatory: Bind LPS, suppress LPS-induced cytokines IL-6 and TNF-alpha. Viruses:
Evidence 12 Activity

Activity

MIC
Antifungal
4 µM

Target

B. megaterium Bm11

Source & Reference

dbAMP DRAMP Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
active against Gram+ S. aureus ATCC25923 or Cowan 1 (MIC 32-64), B. megaterium Bm11 (MIC 4 uM), S. epidermidis LY8 (MIC 25 ug/ml), L. monocytogenes CICC21634 or CICC21533 (MIC 4-125 ug
Evidence 13 Activity

Activity

MIC
Antifungal
25 µg/mL

Target

Staphylococcus epidermidis LY8

Source & Reference

dbAMP DRAMP Antifungipept

Other

against Gram+ S. aureus ATCC25923 or Cowan 1 (MIC 32-64), B. megaterium Bm11 (MIC 4 uM), S. epidermidis LY8 (MIC 25 ug/ml), L. monocytogenes CICC21634 or CICC21533 (MIC 4-125 ug/ml), B. subtilis CICC24434 (MIC 1.
Evidence 14 Activity

Activity

MIC
Antifungal
4-125 µg/mL

Target

L. monocytogenes CICC21634 or CICC21533

Source & Reference

dbAMP DRAMP Antifungipept

Other

or Cowan 1 (MIC 32-64), B. megaterium Bm11 (MIC 4 uM), S. epidermidis LY8 (MIC 25 ug/ml), L. monocytogenes CICC21634 or CICC21533 (MIC 4-125 ug/ml), B. subtilis CICC24434 (MIC 1.56 ug/ml), B. Globigii (MIC 0.6 uM), Gram- S. choleraesuis
Evidence 15 Activity

Activity

MIC
Antifungal
1.56 µg/mL

Target

B. subtilis CICC24434

Source & Reference

dbAMP DRAMP Antifungipept

Other

pidermidis LY8 (MIC 25 ug/ml), L. monocytogenes CICC21634 or CICC21533 (MIC 4-125 ug/ml), B. subtilis CICC24434 (MIC 1.56 ug/ml), B. Globigii (MIC 0.6 uM), Gram- S. choleraesuis C78-1 (MIC 1.56 ug/ml), S. typhimurium S
Evidence 16 Activity

Activity

MIC
Antifungal
0.6 µM

Target

B. Globigii

Source & Reference

dbAMP DRAMP Antifungipept

Other

togenes CICC21634 or CICC21533 (MIC 4-125 ug/ml), B. subtilis CICC24434 (MIC 1.56 ug/ml), B. Globigii (MIC 0.6 uM), Gram- S. choleraesuis C78-1 (MIC 1.56 ug/ml), S. typhimurium SL1344 (MIC 3.12-4 ug/ml),
Evidence 17 Activity

Activity

MIC
Antifungal
1.56 µg/mL

Target

S. choleraesuis C78-1

Source & Reference

dbAMP DRAMP Antifungipept

Other

MIC 4-125 ug/ml), B. subtilis CICC24434 (MIC 1.56 ug/ml), B. Globigii (MIC 0.6 uM), Gram- S. choleraesuis C78-1 (MIC 1.56 ug/ml), S. typhimurium SL1344 (MIC 3.12-4 ug/ml), P. avium C48-3 (MIC 3.12 ug/ml), S. choleraesu
Evidence 18 Activity

Activity

MIC
Antifungal
3.12-4 µg/mL

Target

S. typhimurium SL1344

Source & Reference

dbAMP DRAMP Antifungipept

Other

(MIC 1.56 ug/ml), B. Globigii (MIC 0.6 uM), Gram- S. choleraesuis C78-1 (MIC 1.56 ug/ml), S. typhimurium SL1344 (MIC 3.12-4 ug/ml), P. avium C48-3 (MIC 3.12 ug/ml), S. choleraesuis C78-1 (MIC 1.56 ug/ml), E. coli ATCC 25
Evidence 19 Activity

Activity

MIC
Antifungal
3.12 µg/mL

Target

P. avium C48-3

Source & Reference

dbAMP DRAMP Antifungipept

Other

, Gram- S. choleraesuis C78-1 (MIC 1.56 ug/ml), S. typhimurium SL1344 (MIC 3.12-4 ug/ml), P. avium C48-3 (MIC 3.12 ug/ml), S. choleraesuis C78-1 (MIC 1.56 ug/ml), E. coli ATCC 25922 (MIC 1-2 uM), and P. aerugino
Evidence 20 Activity

Activity

MIC
Antifungal
1.56 µg/mL

Target

S. choleraesuis C78-1

Source & Reference

dbAMP DRAMP Antifungipept

Other

C 1.56 ug/ml), S. typhimurium SL1344 (MIC 3.12-4 ug/ml), P. avium C48-3 (MIC 3.12 ug/ml), S. choleraesuis C78-1 (MIC 1.56 ug/ml), E. coli ATCC 25922 (MIC 1-2 uM), and P. aeruginosa ATCC 27853 or PAO1 (MIC 1.25-2.5 uM).
Evidence 21 Activity

Activity

MIC
Antifungal
1-2 µM

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP DRAMP Antifungipept

Other

C 3.12-4 ug/ml), P. avium C48-3 (MIC 3.12 ug/ml), S. choleraesuis C78-1 (MIC 1.56 ug/ml), E. coli ATCC 25922 (MIC 1-2 uM), and P. aeruginosa ATCC 27853 or PAO1 (MIC 1.25-2.5 uM). Anti-inflammatory: Bind LPS, sup
Evidence 22 Activity

Activity

MIC
Antifungal
1.25-2.5 µM

Target

Pseudomonas aeruginosa ATCC 27853 or PAO1

Source & Reference

dbAMP DRAMP Antifungipept

Other

3.12 ug/ml), S. choleraesuis C78-1 (MIC 1.56 ug/ml), E. coli ATCC 25922 (MIC 1-2 uM), and P. aeruginosa ATCC 27853 or PAO1 (MIC 1.25-2.5 uM). Anti-inflammatory: Bind LPS, suppress LPS-induced cytokines IL-6 and TNF-alpha. Viruses:
Evidence 23 Activity

Activity

MIC
Antiparasitic
4 µM

Target

B. megaterium Bm11

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
active against Gram+ S. aureus ATCC25923 or Cowan 1 (MIC 32-64), B. megaterium Bm11 (MIC 4 uM), S. epidermidis LY8 (MIC 25 ug/ml), L. monocytogenes CICC21634 or CICC21533 (MIC 4-125 ug
Evidence 24 Activity

Activity

MIC
Antiparasitic
25 µg/mL

Target

Staphylococcus epidermidis LY8

Source & Reference

DRAMP

Other

against Gram+ S. aureus ATCC25923 or Cowan 1 (MIC 32-64), B. megaterium Bm11 (MIC 4 uM), S. epidermidis LY8 (MIC 25 ug/ml), L. monocytogenes CICC21634 or CICC21533 (MIC 4-125 ug/ml), B. subtilis CICC24434 (MIC 1.
Evidence 25 Activity

Activity

MIC
Antiparasitic
4-125 µg/mL

Target

L. monocytogenes CICC21634 or CICC21533

Source & Reference

DRAMP

Other

or Cowan 1 (MIC 32-64), B. megaterium Bm11 (MIC 4 uM), S. epidermidis LY8 (MIC 25 ug/ml), L. monocytogenes CICC21634 or CICC21533 (MIC 4-125 ug/ml), B. subtilis CICC24434 (MIC 1.56 ug/ml), B. Globigii (MIC 0.6 uM), Gram- S. choleraesuis
Evidence 26 Activity

Activity

MIC
Antiparasitic
1.56 µg/mL

Target

B. subtilis CICC24434

Source & Reference

DRAMP

Other

pidermidis LY8 (MIC 25 ug/ml), L. monocytogenes CICC21634 or CICC21533 (MIC 4-125 ug/ml), B. subtilis CICC24434 (MIC 1.56 ug/ml), B. Globigii (MIC 0.6 uM), Gram- S. choleraesuis C78-1 (MIC 1.56 ug/ml), S. typhimurium S
Evidence 27 Activity

Activity

MIC
Antiparasitic
0.6 µM

Target

B. Globigii

Source & Reference

DRAMP

Other

togenes CICC21634 or CICC21533 (MIC 4-125 ug/ml), B. subtilis CICC24434 (MIC 1.56 ug/ml), B. Globigii (MIC 0.6 uM), Gram- S. choleraesuis C78-1 (MIC 1.56 ug/ml), S. typhimurium SL1344 (MIC 3.12-4 ug/ml),
Evidence 28 Activity

Activity

MIC
Antiparasitic
1.56 µg/mL

Target

S. choleraesuis C78-1

Source & Reference

DRAMP

Other

MIC 4-125 ug/ml), B. subtilis CICC24434 (MIC 1.56 ug/ml), B. Globigii (MIC 0.6 uM), Gram- S. choleraesuis C78-1 (MIC 1.56 ug/ml), S. typhimurium SL1344 (MIC 3.12-4 ug/ml), P. avium C48-3 (MIC 3.12 ug/ml), S. choleraesu
Evidence 29 Activity

Activity

MIC
Antiparasitic
3.12-4 µg/mL

Target

S. typhimurium SL1344

Source & Reference

DRAMP

Other

(MIC 1.56 ug/ml), B. Globigii (MIC 0.6 uM), Gram- S. choleraesuis C78-1 (MIC 1.56 ug/ml), S. typhimurium SL1344 (MIC 3.12-4 ug/ml), P. avium C48-3 (MIC 3.12 ug/ml), S. choleraesuis C78-1 (MIC 1.56 ug/ml), E. coli ATCC 25
Evidence 30 Activity

Activity

MIC
Antiparasitic
3.12 µg/mL

Target

P. avium C48-3

Source & Reference

DRAMP

Other

, Gram- S. choleraesuis C78-1 (MIC 1.56 ug/ml), S. typhimurium SL1344 (MIC 3.12-4 ug/ml), P. avium C48-3 (MIC 3.12 ug/ml), S. choleraesuis C78-1 (MIC 1.56 ug/ml), E. coli ATCC 25922 (MIC 1-2 uM), and P. aerugino
Evidence 31 Activity

Activity

MIC
Antiparasitic
1.56 µg/mL

Target

S. choleraesuis C78-1

Source & Reference

DRAMP

Other

C 1.56 ug/ml), S. typhimurium SL1344 (MIC 3.12-4 ug/ml), P. avium C48-3 (MIC 3.12 ug/ml), S. choleraesuis C78-1 (MIC 1.56 ug/ml), E. coli ATCC 25922 (MIC 1-2 uM), and P. aeruginosa ATCC 27853 or PAO1 (MIC 1.25-2.5 uM).
Evidence 32 Activity

Activity

MIC
Antiparasitic
1-2 µM

Target

Escherichia coli ATCC 25922

Source & Reference

DRAMP

Other

C 3.12-4 ug/ml), P. avium C48-3 (MIC 3.12 ug/ml), S. choleraesuis C78-1 (MIC 1.56 ug/ml), E. coli ATCC 25922 (MIC 1-2 uM), and P. aeruginosa ATCC 27853 or PAO1 (MIC 1.25-2.5 uM). Anti-inflammatory: Bind LPS, sup
Evidence 33 Activity

Activity

MIC
Antiparasitic
1.25-2.5 µM

Target

Pseudomonas aeruginosa ATCC 27853 or PAO1

Source & Reference

DRAMP

Other

3.12 ug/ml), S. choleraesuis C78-1 (MIC 1.56 ug/ml), E. coli ATCC 25922 (MIC 1-2 uM), and P. aeruginosa ATCC 27853 or PAO1 (MIC 1.25-2.5 uM). Anti-inflammatory: Bind LPS, suppress LPS-induced cytokines IL-6 and TNF-alpha. Viruses:
Evidence 34 Activity

Activity

10% Hemolysis
Toxicity
10 µM
Hemolytic Cytotoxic
10% Hemolysis | 10 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
PMAP-37, a novel antibacterial peptide from pig myeloid cells. cDNA cloning, chemical synthesis and activity. | Eur J Biochem | 1995
Evidence 35 Activity

Activity

30% Hemolysis
Toxicity
50 µM
Hemolytic Cytotoxic
30% Hemolysis | 50 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
PMAP-37, a novel antibacterial peptide from pig myeloid cells. cDNA cloning, chemical synthesis and activity. | Eur J Biochem | 1995
Evidence 36 Activity

Activity

<4% Hemolysis
Toxicity
1000 µg/mL
Hemolytic Cytotoxic
<4% Hemolysis | 1000 | µg/mL | target cell: Mouse erythrocytes

Target

Mouse erythrocytes

Source & Reference

NA
DBAASP
Enhancing the antibacterial activity of PMAP-37 by increasing its hydrophobicity. | Chem Biol Drug Des | 2019
Evidence 37 Activity

Activity

Toxicity
Cytotoxic
NA | target cell: Mouse fibroblasts NIH 3T3

Target

Mouse fibroblasts NIH 3T3

Source & Reference

NA
DBAASP
Enhancing the antibacterial activity of PMAP-37 by increasing its hydrophobicity. | Chem Biol Drug Des | 2019
Evidence 38 Activity

Activity

<5% Hemolysis
Toxicity
1000 µg/mL
Hemolytic Cytotoxic
<5% Hemolysis | 1000 | µg/mL | target cell: Mouse erythrocytes

Target

Mouse erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial Peptide PMAP-37 Analogs: Increasing the Positive Charge to Enhance the Antibacterial Activity of PMAP-37. | J Pept Sci | 2019
Evidence 39 Hemolysis

Source & Reference

APD_complete HemoPI PD_Hemolysis
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.